SEARCH

SEARCH BY CITATION

References

  • Albers JM, Möddel G, Dittrich R, Steidl C, Suntrup S, Ringelstein EB, Dziewas R. (2011) Intravenous lacosamide – an effective add-on treatment of refractory status epilepticus. Seizure 20:428430.
  • Alldredge BK, Gelb AM, Isaacs SM, Corry MD, Allen F, Ulrich S, Gottwald MD, O'Neil N, Neuhaus JM, Segal MR, Lowenstein DH. (2001) A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 345:631637. Erratum in: N Engl J Med 2001;345:1860.
  • Andurkar SV, Stables JP, Kohn H. (1999) The anticonvulsant activities of N-benzyl 3-methoxypropionamides. Bioorg Med Chem 7:23812389.
  • Barton ME, Klein BD, Wolf HH, White HS. (2001) Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy. Epilepsy Res 47:217227.
  • Ben-Menachem E, Biton V, Jatuzis D, Abou-Khalil B, Doty P, Rudd GD. (2007) Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures. Epilepsia 48:13081317.
  • Beyreuther BK, Heers C, Krebsfänger N, Scharfenecker U, Stöhr T. (2007) Lacosamide: a review of preclinical properties. CNS Drug Rev 13:2142.
  • Biton V, Rosenfeld WE, Whitesides J, Fountain NB, Vaiciene N, Rudd GD. (2008) Intravenous lacosamide as replacement for oral lacosamide in patients with partial-onset seizures. Epilepsia 49:418424.
  • Borowicz KK, Gasior M, Kleinrok Z, Czuczwar SJ. (1997) Influence of isradipine, niguldipine and dantrolene on the anticonvulsive action of conventional antiepileptics in mice. Eur J Pharmacol 323:4551.
  • Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, Laroche SM, Riviello JJ Jr, Shutter L, Sperling MR, Treiman DM, Vespa PM; Neurocritical Care Society Status Epilepticus Guideline Writing Committee. (2012) Guidelines for the evaluation and management of status epilepticus. Neurocrit Care Apr 24; doi: 10.1007/s12028-012-9695-z. [Epub ahead of print].
  • Cawello W, Kropeit D, Schiltmeyer B, Hammes W, Horstmann R. (2004) Food does not affect the pharmacokinetics of SPM 927. Epilepsia 45(Suppl. 7):307 [Poster 2.342].
  • Chen LL, Haneef Z, Dorsch A, Keselman I, Stern JM. (2011) Successful treatment of refractory simple motor status epilepticus with lacosamide and levetiracetam. Seizure 20:263265.
  • Cherry S, Judd L, Muniz JC, Elzawahry H, LaRoche S. (2012) Safety and efficacy of lacosamide in the intensive care unit. Neurocrit Care 16:294298.
  • Cross SA, Curran MP. (2009) Lacosamide: in partial-onset seizures. Drugs 69:449459.
  • Doty P, Rudd GD, Stoehr T, Thomas D. (2007) Lacosamide. Neurotherapeutics 4:145148.
  • Duncan GE, Kohn H. (2005) The novel antiepileptic drug lacosamide blocks behavioural and brain metabolic manifestations of seizure activity in the 6 Hz psychomotor seizure model. Epilepsy Res 67:8187.
  • Errington AC, Coyne L, Stohr T, Selve N, Lees G. (2006) Seeking a mechanism of action for the novel anticonvulsant lacosamide. Neuropharmacology 50:10161029.
  • Fountain NB, Krauss G, Isojarvi J, Dilley D, Doty P, Rudd GD. (2011) Followed by oral maintenance as adjunctive therapy in patients with partial-onset seizures. Epilepsia 52(Suppl. 8):7285 [Poster 24].
  • Goodwin H, Hinson HE, Shermock KM, Karanjia N, Lewin JJ 3rd. (2011) The use of lacosamide in refractory status epilepticus. Neurocrit Care 14:348353.
  • Granda-Mendez J, Toledo M, Flores-Flores A, Santamarina E, Sarria S, Salas-Puig J. (2011) Intravenous lacosamide in monotherapy in a case of complex partial epileptic status. Rev Neurol 53:6163.
  • Höfler J, Unterberger I, Dobesberger J, Kuchukhidze G, Walser G, Trinka E. (2011) Intravenous lacosamide in status epilepticus and seizure clusters. Epilepsia 52:148152.
  • Horstmann R, Bonn R, Cawello W, Doty P, Rudd D. (2002) Basic clinical pharmacological investigations of the new antiepileptic drug SPM 927. Epilepsia 43(Suppl. 7): 188 [Poster 2.174].
  • Hovinga CA. (2003) SPM-927 (Schwarz Pharma). IDrugs 6:479485.
  • Jain V, Harvey SA. (2012) Treatment of refractory tonic status epilepticus with intravenous lacosamide. Epilepsia 53:761762.
  • Jatuzis D, Biton V, Ben-Menachem E, Abou-Khalil B, Doty P, Rudd GD; SP667 Study Group. (2005) Evaluation of the effect of oral lacosamide on concomitant AED plasma concentrations in patients with partial seizures. Epilepsia 46(Suppl. 8):170 [Poster 2.236].
  • Kellinghaus C, Berning S, Besselmann M. (2009) Intravenous lacosamide as successful treatment for nonconvulsive status epilepticus after failure of first-line therapy. Epilepsy Behav 14:429431.
  • Kellinghaus C, Berning S, Immisch I, Larch J, Rosenow F, Rossetti AO, Tilz C, Trinka E. (2011) Intravenous lacosamide for treatment of status epilepticus. Acta Neurol Scand 123:137141. Epub 2010 Sep 26.
  • Koubeissi MZ, Mayor CL, Estephan B, Rashid S, Azar NJ. (2011) Efficacy and safety of intravenous lacosamide in refractory nonconvulsive status epilepticus. Acta Neurol Scand 123:142146.
  • Krause LU, Brodowski KO, Kellinghaus C. (2011) Atrioventricular block following lacosamide intoxication. Epilepsy Behav 20:725727.
  • Krauss G, Ben-Menachem E, Mameniskiene R, Vaiciene-Magistris N, Brock M, Whitesides JG, Johnson ME; SP757 Study Group. (2010) Intravenous lacosamide as short-term replacement for oral lacosamide in partial-onset seizures. Epilepsia 51:951957.
  • Kropeit D, Schildtmeyer B, Cawello W, Hammes W, Horstmann R. (2004) Bioequivalence of short-time infusions compared to oral administration of SPM 927. Epilepsia 45(Suppl. 7):123124 [Poster 1.323].
  • Kurthen M, Janzen R, Lerche H, Schmidt D, Schneider D, Stefan H, Steinhoff B, Trinka E, Wieser H. (2008) Status epilepticus im Erwachsenenalter. In Diener HC, Putzki N, Berlit P, Deuschl G, Elger C, Gold R, Hacke W, Hufschmidt A, Mattle H, Meier U, Oertel WH, Reichmann H, Schmutzhard E, Wallesch CW, Weller M (Eds) Leitlinien für Diagnostik und Therapie in der Neurologie. 3. Auflage. Thieme, Stuttgart, pp. 1728.
  • LaRoche SM, Shivdat-Nanhoe RS. (2011) Subacute encephalopathy and seizures in alcoholics (SESA) presenting with non-convulsive status epilepticus. Seizure 20:505508.
  • Leppik IE, Derivan AT, Homan RW, Walker J, Ramsay RE, Patrick B. (1983) Double-blind study of lorazepam and diazepam in status epilepticus. JAMA 249:14521454.
  • Meierkord H, Boon P, Engelsen B, Göcke K, Shorvon S, Tinuper P, Holtkamp M; European Federation of Neurological Societies. (2010) EFNS guideline on the management of status epilepticus in adults. Eur J Neurol 17:348355.
  • Mnatsakanyan L, Chung JM, Tsimerinov EI, Eliashiv DS. (2012) Intravenous lacosamide in refractory nonconvulsive status epilepticus. Seizure 21:198201.
  • Parkerson KA, Reinsberger C, Chou SH, Dworetzky BA, Lee JW. (2011) Lacosamide in the treatment of acute recurrent seizures and periodic epileptiform patterns in critically ill patients. Epilepsy Behav 20:4851.
  • Rantsch K, Walter U, Wittstock M, Benecke R, Rösche J. (2011) Efficacy of intravenous lacosamide in refractory nonconvulsive status epilepticus and simple partial status epilepticus. Seizure 20:529532.
  • Shiloh-Malawsky Y, Fan Z, Greenwood R, Tennison M. (2011) Successful treatment of childhood prolonged refractory status epilepticus with lacosamide. Seizure 20:586588.
  • Shorvon S, Baulac M, Cross H, Trinka E, Walker M; Task Force on Status Epilepticus of the ILAE Commission for European Affairs. (2008) The drug treatment of status epilepticus in Europe: consensus document from a workshop at the first London Colloquium on Status Epilepticus. Epilepsia 49:12771285.
  • Silbergleit R, Durkalski V, Lowenstein D, Conwit R, Pancioli A, Palesch Y, Barsan W; NETT Investigators. (2012) Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med 366:591600.
  • Stöhr T, Kupferberg HJ, Stables JP, Choi D, Harris RH, Kohn H, Walton N, White HS. (2007) Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy. Epilepsy Res 74:147154.
  • Swinyard EA, Brown WC, Goodman LS. (1952) Comparative assays of antiepileptic drugs in mice and rats. J Pharmacol Exp Ther 106:319330.
  • Tilz C, Resch R, Hofer T, Eggers C. (2010) Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide. Epilepsia 51:316317.
  • Torres-Cano N, Giner Bayarri P, Chilet-Chilet MR, Ruiz-Marquez L, Rodrigo-Sanbartolome A, Mazzillo-Ricaurte A, Moliner-Ibanez J. (2011) Refractory nonconvulsive status epilepticus. Rev Neurol 53:255256.
  • Treiman DM, Meyers PD, Walton NY, Collins JF, Colling C, Rowan AJ, Handforth A, Faught E, Calabrese VP, Uthman BM, Ramsay RE, Mamdani MB. (1998) A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 339:792798.
  • Trinka E. (2007) Notfälle im Bereich der Epilepsien – Was tun und was lassen? Nervenheilkunde 26:981992.
  • Turpin-Fenoll L, Millan-Pascual J, Navarro-Munoz S, del Saz-Saucedo P, Rueda-Medina I. (2010) Uso de lacosamida oral en un paciente con estado epileptico parcial refractario. Rev Neurol 50:603606.
  • Wasterlain CG, Stöhr T, Matagne A. (2011) The acute and chronic effects of the novel anticonvulsant lacosamide in an experimental model of status epilepticus. Epilepsy Res 94:1017.